�Scientists from The Institute of Advanced Studies at Princeton and the University of California discovered that the inherent process in tumor formation is the same as for life itself - evolution. After analyzing a half meg gene mutations, the researchers found that although different gene mutations control different cancer pathways, each pathway was controlled by only one congeal of factor mutations. This suggests that a molecular "survival of the fittest" scenario plays out in every living creature as gene mutations strive for ultimate endurance through cancerous tumors. This finding, which appears in the August 2008 topic of The FASEB Journal (http://www.fasebj.org), improves our understanding of how evolution shapes life history in all forms, patch laying a foundation for new cancer drugs and treatments.
"This sketch lays the groundwork for understanding the nature of different mutations in cancers," said Chen-Hsiang Yeung, first-class honours degree author of the cogitation, "and helps with intellect the mechanisms of cancers and their responses to drug treatments."
To arrive at these conclusions, researchers analyzed about five hundred,000 cancer the Crab mutation records from the Catalog of Somatic Mutations in Cancer database and then dual-lane the information into 45 tissue types. Within each tissue type, they deliberate the frequency that multiple genes were mutated in the same sample. They identified the frequencies of mutations that were significantly higher or lower than if the genes had mutated independently. Then they mapped out how these genes at last lead to cancerous tumors and chequered whether the genes occurring in specific tissues used the same or different cancer pathways.
"Little could Darwin have known that his 'Origin of the Species' would unitary day explain the 'Origin of the Tumor,'" aforementioned Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal. "This research report totally changes our understanding of the many gene mutations that causal agency cancer."
The FASEB Journal (world Wide Web.fasebj.org) is published by the Federation of American Societies for Experimental Biology (FASEB) and is the nigh cited biota journal worldwide according to the Institute for Scientific Information. FASEB comprises 21 nonprofit societies with more than 80,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB advances biological science through collaborative advocacy for enquiry policies that promote scientific progress and education and lead to improvements in human health.
"Combinatorial patterns of somatic cistron mutations in cancer"Chen-Hsiang Yeang, Frank McCormick, and Arnold Levine
FASEB J. 2008 22: 2605-2622
Click here to view abstract onlineCody Mooneyhan
Federation of American Societies for Experimental Biology
www.fasebj.org
More information
